Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is marketed by Janssen Pharmaceuticals. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing
A Anant Labs fabrica e fornece impurezas de Paliperidone de alta qualidade para o mercado global. Nossas impurezas EP de Paliperidone são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
Paliperidone144598-75-49-HydroxyrisperidoneInvegaRO76477R-76477PaliperidonaRO-764774H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-R 76477NSC-7596233-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-838F01T721(9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl))ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-4-one4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8-tetrahydro-9-hydroxy-2-methyl-4H-Pyrido(2,1-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-DTXSID7049059paliperidonumTrevicta9 OH risperidone(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido(1,2-a)pyrimidin-4-one3-(2-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]ETHYL)-9-HYDROXY-2-METHYL-4H,6H,7H,8H,9H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE9 Hydroxyrisperidone9 Hydroxy risperidoneRefChem:56592CHEBI:82978DTXCID30210372N05AX13R764773-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one9-Hydroxy-risperidoneC23H27FN4O33-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-oneMFCD008718023-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-oneCHEMBL16216,7,8,9-Tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl-4H-pyrido[2,1-a]pyrimidin-4-onePaliperidone [INN]9-hydroxy risperidone3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-onePALLIPERIDONEHSDB 8148RAC 9-HYDROXY RISPERIDONEUNII-838F01T7213-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-9-HYDROXY-2-METHYL-4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-onePaliperidone [USAN:INN:BAN:JAN]144598-75-4 (free base)Invega (TN)MFCD09955571Paliperidone (Standard)Risperidone-M 9-hydroxyPALIPERIDONE [MI]PALIPERIDONE [JAN]PALIPERIDONE [USAN]PALIPERIDONE [VANDF]PALIPERIDONE [MART.]JNS-007ERMLS004773953PALIPERIDONE [USP-RS]PALIPERIDONE [WHO-DD]SCHEMBL436689Paliperidone (JAN/USP/INN)GTPL7258orb1310964orb3141216Paliperidone9-hydroxyrisperidonePALIPERIDONE [EMA EPAR]SCHEMBL29409219CHEBI:83804HY-A0019RPaliperidone - Bio-X trade markPaliperidone, >=98% (HPLC)HMS3261B06HMS3743M09HMS3887K15HMS5087B15PALIPERIDONE [ORANGE BOOK]HY-A0019MSK10469**See P141000**PALIPERIDONE [USP MONOGRAPH]Tox21_500562BDBM50252513EBC-13192HB1798s1724AKOS005266713AKOS016339656AKOS025392164AC-1282CCG-221866CS-0386DB01267FP26725KS-1279LP00562NSC 759623PB27526SDCCGSBI-0633730.P001Risperidone EP Impurity C; PaliperidoneNCGC00186014-01NCGC00186014-12NCGC00261247-013-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one9-Hydroxyrisperidone, 1mg/ml in MethanolAS-13860BP164223Risperidone EP Impurity C (Paliperidone)SMR001456280SY026871Risperidone impurity, 9-hydroxyrisperidone-9-Hydroxyrisperidone 1.0 mg/ml in MethanolP1897RISPERIDONE IMPURITY C [EP IMPURITY]C21516D05339EN300-119503F358079L023985Q423292SR-02000000862SR-02000000862-3BRD-A99888680-001-03-8BRD-A99888680-001-04-6Z1521553597Paliperidone, United States Pharmacopeia (USP) Reference StandardRISPERIDONE IMPURITY, 9-HYDROXYRISPERIDONE- [USP IMPURITY](+/-)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (9-Hydroxyrisperidone)3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one3-[ 2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin4-one3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 9-Hydroxyrisperidone3-[2-[4-(6-Fluoro-1,2-Benzisoxazol-3-yl)-1-Piperidinyl]Ethyl]-9-Hydroxy-6,7,8,9-Tetrahydro-2-Methyl-4H-Pyrido[1,2-a]-Pyrimidin-4-One3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidyl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one3-{2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidinyl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-alpha]pyrimidin-4-one4H-yrido[1,2-]yrimidin-4-ne, 3-2-4-(6-luoro-1,2-enzisoxazol-3-l)-1-iperidinyl]thyl]-6,7,8,9-etrahydro-9-ydroxy-2-ethyl-
